Cutting Edge MarinBio Science Newsletter

Looking for a partner with 30 years of proven expertise in taking drugs from development to validation and FDA approval?
Contact us @ 415.883.8000

Marin Biologic Laboratories official logo, representing their expertise in custom assay development and FDA registered contract laboratory services.

Advancing PROTAC Therapeutics: Potency Assays for FDA Compliance

Related News – Marin Bio Successfully Passes FDA Inspection & Expands Services What are PROTACs? Proteolysis Targeting Chimeric (PROTAC) drugs are innovative molecules that utilize the ubiquitin-proteasome system to selectively degrade specific proteins within cells. PROTACs are one of the most promising methods for targeted protein degradation (TDP), which is used to remove disease-causing or disease-associated….

Recent Articles